Study of Atomoxetine in the Prevention of Vasovagal Syncope
Study of Atomoxetine in the Prevention of Vasovagal Syncope
Recruiting · NCT05159687 · Registry updated 2024-05-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Atomoxetine in the Prevention of Vasovagal Syncope | Consciousness Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Syncope, Syncope, Vasovagal, Unconsciousness, autonomic nervous system disorder, nervous system disorder, orthostatic intolerance, primary dysautonomia | Recruiting | Phase 3 | 2024-05-09 | NCT05159687 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Calgary | 238 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Calgary | Calgary | Canada | 44 |